Skip to the card

2026-11-09 issue

Observed arrival · 2026-11-09

OpenLandscape’s sourced drug-pipeline maps

openlandscape.app Visit website
Editorial interest 82/100 Selection signal · not a rating of the site

A disease-by-disease drug-development tracker that organizes programs, stages, and milestones, with source links and an AI-agent connector.

Landing page captured for the 2026-11-09 issue.
For
Drug-development researchers tracking disease-specific pipelines
Worth noticing
The obesity example lists 98 mid- or late-stage drugs, including 25 from China-based companies, alongside trial counts and milestone dates.

Field notes

The public obesity example pairs programs with companies, stages, indications, trial counts, and milestone dates. The site says its weekday change feed covers new trials, phase or status changes, moved dates, and SEC deal or financing filings; it also offers an MCP connector for pipeline questions through compatible AI clients, with source links in responses.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
⊠LoginAccess appeared gated
$PaidCommerce or pricing visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use

One card from the complete issue

Restoration Without a Chisel

251,529 arrived 1,000 judged 974 catalogued Enter the complete issue
openlandscape.app

Landing page observed 2026-11-09. The live site may have changed.